Stability determination of solid lipid nanoparticles (SLN®) in aqueous dispersion after addition of electrolyte

Journal of Microencapsulation

Volumn 16, Issue 1, 1999, Pages 59-71

  Freitas, C ^a   Muller R H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Electrolytes; Gelation; Lipid modification; Solid lipid nanoparticles; Stability; Zeta potential

Indexed keywords

ALUMINUM CHLORIDE; CALCIUM CHLORIDE; ELECTROLYTE; ION; LIPID; NANOPARTICLE; SODIUM CHLORIDE;

ARTICLE; CONCENTRATION RESPONSE; CRYSTALLIZATION; DISPERSION; ELECTRICITY; GEL; GROWTH; SOLID; ZETA POTENTIAL;

ALUMINUM COMPOUNDS; CALCIUM CHLORIDE; CATIONS; CHLORIDES; DRUG CARRIERS; DRUG STABILITY; ELECTROLYTES; EXCIPIENTS; FATTY ACIDS; GELS; LIPIDS; PARTICLE SIZE; POLOXAMER; SODIUM CHLORIDE; TEMPERATURE;

EID: 0344959598     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/026520499289310     Document Type: Article

References (25)

1. FREITAS, C., and MÜLLER, R. H., 1997, Long-term stability of solid lipid nanoparticles (SLN™), Influence of crystallinity of the lipid and shear forces. European Pharmaceutics, Biopharmaceutics (In press).
2. FREITAS, C., and MÜLLER, R. H., 1998, Effect of light and temperature on zeta potential and physical stability in Solid Lipid Nanoparticles (SLN™) dispersions. International Journal of Pharmaceutics, 221-229.
3. FREITAS, C., LUCKS, J. S., and MÜLLER, R. H., 1995, Effect of storage conditions on long-term stability of solid lipid nanoparticles (SLN) in aqueous dispersion. Proceedings of the 1st world meeting APGI/APV, Budapest, 9-11 May, 493-494.
4. GARTI, N., 1988, Effects of surfactants on crystallization and polymorphic transformation of fats and fatty acids. In Crystallization and polymorphism of fats and fatty acids, edited by N. Garti and K. Sato (New York, Basel: Marcel Dekker Inc.), pp. 267-304.
5. HAGEMANN, J. W., 1988, Thermal behavior and polymorphism of acylglycerides. In Crystallization and polymorphism of fats and fatty acids, edited by N. Garti and K. Sato (New York, Basel: Marcel Dekker Inc.), pp. 9-96.
6. LUCKS, J. S., 1993, Parenterale Fettemulsionen als Arzneistoffträger, Herstellung, Charakterisierung und Stabilität. Ph.D. thesis, Christian Albrechts University Kiel.
7. MORI, H., 1988, Solidification problems in preparation of fats. In Crystallization and polymorphism of fats and fatty acids, edited by N. Garti and K. Sato (New York, Basel: Marcel Dekker Inc.), pp. 423-442.
8. MÜLLER, R. H., 1996, Zetapotential und Partikelladung in der Laborpraxis. APV Paperback, Vol. 37 (Stuttgart: Wissenschaftliche Veragsgesellschaft).
9. MÜLLER, R. H., and HEINEMANN, S., 1992, Fat emulsions for parenteral nutrition. I. Evaluation of microscopic and laser light scattering methods for the determination of the physical stability. Clinical Nutrition, 11, 223-236.
10. MÜLLER, R. H., and HEINEMANN, S., 1993, Fat emulsions for parenteral nutrition. II. Characterization and physical long-term stability of Lipofundin MCT/LCT. Clinical Nutrition, 12, 298-309.
11. MÜLLER, R. H., and HEINEMANN, S., 1994a, Fat emulsions for parenteral nutrition. III. Lipofundin MCT/LCT regimens for total arenteral nutrition (TPN) with low electrolyte load. International Journal of Pharmaceutics, 101, 175-189.
12. MÜLLER, R. H., and HEINEMANN, S., 1994b. Fat emulsions for parenteral nutrition. IV. Lipofundin MCT/LCT regimes for total parenteral nutrition (TPN) with high electrolyte load. International Journal of Pharmaceutics, 107, 121-132.
13. MÜLLER, R. H., and LUCKS, J. S., 1996, Mediation vehicles made of solid lipid particles (solid lipid nanospheres - SLN). European Patent EP 0 605 497 B1.
14. MÜLLER, R. H., MEHNERT, W., LUCKS, J. S., SCHWARZ, C., ZUR MÜHLEN, A., WEYHERS, H., FREITAS, C., and RÜHL, D., 1995, Solid lipid nanoparticles (SLN) - An alternative colloidal carrier system for controlled drug delivery. European Pharmaceutics, Biopharmaceutics, 41, 62-69.
15. RIDDICK, T. M., 1968, Zeta-Meter Manual (New York: Zeta Inc.).
16. SATO, K., 1988, Crystallization of fats and fatty acids. In Crystallization and polymorphism of fats and fatty acids, edited by N. Garti and K. Sato (New York, Basel: Marcel Dekker Inc.), pp. 227-266.
17. SCHUHMANN, R., 1995, Physikalische Stabilität parenteraler Fettemulsionen - Entwicklung eines Untersuchungsschemas unter besonderem Aspekt analytischer Möglichkeiten. Ph.D. thesis, Freie Universität Berlin.
18. SCHUHMANN, R., MEHNERT, W., and MÜLLER, R. H., 1993, Coulter counter based coalescence assay for the determination of emulsion stability after addition of electrolyte. Pharmaceutics Industry, 55, 701-704.
19. SIEKMANN, B., 1994, Untersuchungen zur Herstellung und zum Rekristallisationsverhalten schmelzemulgierter intravenös applizierbarer Glyceridnanopartikel. Ph.D. thesis, Technical University of Braunschweig.
20. SIEKMANN, B., and WESTESEN, K., 1992, Submicron-sized parenteral carrier systems based on solid lipids. Pharmaceutic and Pharmacology Letters, 1, 123-126.
21. STAMPA, B., LUCKS, J. S., MÜLLER, B. W., and MÜLLER, R. H., 1991, Electrophoretic properties of emulsions for parenteral nutrition determined by laser light scattering and application of the amplitude-weighted phase structure function (AWS). Journal of Colloid Interface Science, 143, 188-194.
22. TARDROS, T. F., and VINCENT, B., 1980, Influence of temperature and electrolytes on the adsorption of poly(ethylene oxide)-poly(propylenene oxide) block copolymer on polystyrene latex and on the stability of the polymer coated particles. Journal of Physical Chemistry, 84, 1575-1580.
23. WEYHERS, H., EHLERS, S., MEHNERT, W., HAHN, H., and MÜLLER, R. H., 1995, Solid lipid nanoparticles - determination of in vivo toxicity. Proceedings of the 1st world meeting APGI/APV, Budapest, 9-11 May, 489-490.
24. ZUR MÜHLEN, A., 1996, Feste Lipid Nanopartikel mit prolongierter Wirkstoffliberation. Herstellung, Langzeitstabilität, Charakterisierung, Freisetzungsverhalten und -mechanismen. Ph.D. thesis, Freie Universität Berlin.
25. ZUR MÜHLEN, A., ZUR MÜHLEN, E., NIEHUS, H., and MEHNERT, W., 1996, Atomic force microscopy studies of solid lipid nanoparticles. Pharmaceutical Research, 13, 1411-1416.